Covid-19: From structure to therapeutic targeting in studying approved drugs and local DNA vaccination.

Wang, Zhiguo; Hong, Xiaojing; Wang, Hongyan; Liu, Jun; Liu, Jun-Ping

Wang, Zhiguo; Hong, Xiaojing; Wang, Hongyan; Liu, Jun; Liu, Jun-Ping.

Wang Z; Institute of Ageing Research, Hangzhou Normal University, School of Medicine, Hangzhou, China.
Hong X; Institute of Ageing Research, Hangzhou Normal University, School of Medicine, Hangzhou, China.
Wang H; Institute of Ageing Research, Hangzhou Normal University, School of Medicine, Hangzhou, China.
Liu J; Institute of Ageing Research, Hangzhou Normal University, School of Medicine, Hangzhou, China.
Liu JP; Institute of Ageing Research, Hangzhou Normal University, School of Medicine, Hangzhou, China.

Clin Exp Pharmacol Physiol ; 47(11): 1771-1773, 2020 11.

Article in English | MEDLINE | ID: covidwho-797818

Subject(s)

Antiviral Agents/therapeutic use; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Vaccines, DNA/therapeutic use; Viral Vaccines/therapeutic use; COVID-19; COVID-19 Vaccines; Coronavirus Infections/prevention & control; Humans; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Vaccines, DNA Topics: Vaccines Limits: Humans Language: English Journal: Clin Exp Pharmacol Physiol Year: 2020 Document Type: Article Affiliation country: 1440-1681.13409

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google